BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 22378485)

  • 41. Percutaneous left ventricular support devices.
    Lee MS; Makkar RR
    Cardiol Clin; 2006 May; 24(2):265-75, vii. PubMed ID: 16781943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. First-in-human experience with Aortix intraaortic pump.
    Vora AN; Schuyler Jones W; DeVore AD; Ebner A; Clifton W; Patel MR
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):428-433. PubMed ID: 30311400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coronary revascularization for patients with severe left ventricular dysfunction.
    Nagendran J; Norris CM; Graham MM; Ross DB; Macarthur RG; Kieser TM; Maitland AM; Southern D; Meyer SR;
    Ann Thorac Surg; 2013 Dec; 96(6):2038-44. PubMed ID: 23968761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multivessel coronary drug-eluting stenting alone in patients with significant ischemic mitral regurgitation: a 4-year follow up.
    Ho PC; Nguyen ME
    J Invasive Cardiol; 2008 Jan; 20(1):41-3. PubMed ID: 18174619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.
    Zishiri ET; Williams S; Cronin EM; Blackstone EH; Ellis SG; Roselli EE; Smedira NG; Gillinov AM; Glad JA; Tchou PJ; Szymkiewicz SJ; Chung MK
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):117-28. PubMed ID: 23275233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.
    Sunagawa G; Komiya T; Tamura N; Sakaguchi G; Kobayashi T; Murashita T
    Ann Thorac Surg; 2010 Jun; 89(6):1896-900; discussion 1900. PubMed ID: 20494045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Left ventricular assist for high-risk percutaneous coronary intervention.
    Jones HA; Kalisetti DR; Gaba M; McCormick DJ; Goldberg S
    J Invasive Cardiol; 2012 Oct; 24(10):544-50. PubMed ID: 23043040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful use of the TandemHeart percutaneous ventricular assist device as a bridge to recovery for acute cellular rejection in a cardiac transplant patient.
    Velez-Martinez M; Rao K; Warner J; Dimaio J; Ewing G; Mishkin JD; Mammen PP; Drazner MH; Markham DW; Patel PC
    Transplant Proc; 2011 Dec; 43(10):3882-4. PubMed ID: 22172864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous coronary intervention in patients refused from surgery: a different entity?
    Montone RA; Niccoli G
    Minerva Cardioangiol; 2018 Oct; 66(5):562-568. PubMed ID: 29527866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical myocardial revascularization versus percutaneous coronary intervention with drug-eluting stents in octogenarian patients.
    Ben-Gal Y; Finkelstein A; Banai S; Medalion B; Weisz G; Genereux P; Moshe S; Pevni D; Aviram G; Uretzky G
    Heart Surg Forum; 2012 Aug; 15(4):E204-9. PubMed ID: 22917825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
    Dixon SR; Henriques JP; Mauri L; Sjauw K; Civitello A; Kar B; Loyalka P; Resnic FS; Teirstein P; Makkar R; Palacios IF; Collins M; Moses J; Benali K; O'Neill WW
    JACC Cardiovasc Interv; 2009 Feb; 2(2):91-6. PubMed ID: 19463408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-risk PCI in acute coronary syndromes with Impella LP 2.5 device support.
    Iliodromitis KE; Kahlert P; Plicht B; Hoffmann AC; Eggebrecht H; Erbel R; Konorza TF
    Int J Cardiol; 2011 Nov; 153(1):59-63. PubMed ID: 20826017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry).
    Shavelle DM; Banerjee S; Maini B; Schreiber TL; Kapasi N; O'Neill WW; Popma J; Matthews RV
    Am J Cardiol; 2018 Sep; 122(6):966-972. PubMed ID: 30057231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction.
    Russo G; Burzotta F; D'Amario D; Ribichini F; Piccoli A; Paraggio L; Previ L; Pesarini G; Porto I; Leone AM; Niccoli G; Aurigemma C; Verdirosi D; Trani C; Crea F
    Int J Cardiol; 2019 Jan; 274():221-225. PubMed ID: 30057165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The acutely occluded left main coronary artery culprit in cardiogenic shock and initial percutaneous coronary intervention: a substudy of the Manitoba "no option" left main PCI registry.
    Hussain F; Nguyen T; Elmayergi N; Ducas J; Minhas K; Vo M; Kass M; Ravandi A; Parmar G; Jassal DS; Tam JW; Freed D; Menkis AH; Philipp RK
    Can J Physiol Pharmacol; 2012 Sep; 90(9):1325-31. PubMed ID: 22913597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of pulmonary hypertension on outcomes of patients with low left ventricular ejection fraction: a propensity analysis.
    Yang C; Li D; Mennett R; Hammond J; Zhang G; Chen D; Lundbye J; Gallagher R
    J Heart Valve Dis; 2012 Nov; 21(6):767-73. PubMed ID: 23409360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical predictors of left ventricular function improvement after percutaneous coronary interventions in patients with ejection fraction below 45%].
    Dudek D; Rzeszutko Ł; Turek P; Sorysz D; Dubiel JS
    Przegl Lek; 2001; 58(7-8):751-4. PubMed ID: 11769380
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stable coronary artery disease and left ventricular dysfunction: The role of revascularization.
    Aksut B; Starling R; Kapadia S
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):777-783. PubMed ID: 28707392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term outcome of stents versus bypass surgery in diabetic and nondiabetic patients with multivessel or left main coronary artery disease: a pooled analysis of 5775 individual patient data.
    Park DW; Kim YH; Song HG; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Chung SH; Choo SJ; Chung CH; Lee JW; Park SJ
    Circ Cardiovasc Interv; 2012 Aug; 5(4):467-75. PubMed ID: 22872052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
    Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
    J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.